EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Real-World Pharmacokinetic and Exposure–Response Characterization of Venetoclax in Chinese Patients with Hematological Malignancies

Zhirui Liu, Xin Liu iD, Qiang Gong, Shiwei Qin, Xiao Zhu, Isabelle Hui-San Kuan, Wen Yao Mak iD, Xiaoqiang Xiang iD, Changsheng Jia, Qian Wang, Lin Cheng, Ling Li

Drug Design, Development and Therapy · 2026

DOI: 10.2147/dddt.s563629 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Zhirui Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, the First Affiliated Hospital of Army Medical University, Chongqing, People's Republic of China. Hauptthemen laut MEDLINE: Bridged Bicyclo Compounds, Heterocyclic, Sulfonamides, Hematologic Neoplasms, Antineoplastic Agents. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bridged Bicyclo Compounds, HeterocyclicSulfonamidesHematologic NeoplasmsAntineoplastic AgentsHumansFemaleMaleMiddle AgedAdultDose-Response Relationship, DrugProspective StudiesAgedYoung AdultChinaEast Asian People

Stichwörter der Autor:innen

exposure-responsehematological malignancytherapeutic drug monitoringvenetoclax

Substanzen

Bridged Bicyclo Compounds, HeterocyclicSulfonamidesvenetoclaxAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Pharmacy, the First Affiliated Hospital of Army Medical University, Chongqing, People's Republic of China.
  • Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmaceutical Science, Fudan University, Shanghai, People's Republic of China.
  • Department of Hematology, the First Affiliated Hospital of Army Medical University, Chongqing, People's Republic of China.
  • State Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Fudan University, Shanghai, People's Republic of China.
  • Momentum Metrix, San Francisco, CA, USA.
  • Institute of Hepatobiliary Diseases of Zhongnan Hospital, Transplant Center of Wuhan University, Wuhan, People's Republic of China.

ORCID-Profile: Xin Liu, Wen Yao Mak, Xiaoqiang Xiang

Zitieren

APA

Liu, Z., Liu, X., Gong, Q., Qin, S., Zhu, X., Kuan, I. H., Mak, W. Y., Xiang, X., Jia, C., Wang, Q., Cheng, L., & Li, L. (2026). Real-World Pharmacokinetic and Exposure–Response Characterization of Venetoclax in Chinese Patients with Hematological Malignancies. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s563629

Vancouver

Liu Z, Liu X, Gong Q, Qin S, Zhu X, Kuan IH, et al. Real-World Pharmacokinetic and Exposure–Response Characterization of Venetoclax in Chinese Patients with Hematological Malignancies. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s563629

BibTeX
@article{Liu2026,
  author = {Liu, Zhirui and Liu, Xin and Gong, Qiang and Qin, Shiwei and Zhu, Xiao and Kuan, Isabelle Hui-San and Mak, Wen Yao and Xiang, Xiaoqiang and Jia, Changsheng and Wang, Qian and Cheng, Lin and Li, Ling},
  title = {Real-World Pharmacokinetic and Exposure–Response Characterization of Venetoclax in Chinese Patients with Hematological Malignancies},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  doi = {10.2147/dddt.s563629}
}
Kostenlos starten →